Tarek Sahmoud - Net Worth and Insider Trading

Tarek Sahmoud Net Worth

The estimated net worth of Tarek Sahmoud is at least $21,999 dollars as of 2024-11-07. Tarek Sahmoud is the Chief Medical Officer of Context Therapeutics Inc and owns about 10,000 shares of Context Therapeutics Inc (CNTX) stock worth over $21,999. Details can be seen in Tarek Sahmoud's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tarek Sahmoud has not made any transactions after 2022-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Tarek Sahmoud

To

Tarek Sahmoud Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tarek Sahmoud owns 1 companies in total, including Context Therapeutics Inc (CNTX) .

Click here to see the complete history of Tarek Sahmoud’s form 4 insider trades.

Insider Ownership Summary of Tarek Sahmoud

Ticker Comapny Transaction Date Type of Owner
CNTX Context Therapeutics Inc 2022-08-16 Chief Medical Officer

Tarek Sahmoud Latest Holdings Summary

Tarek Sahmoud currently owns a total of 1 stock. Tarek Sahmoud owns 10,000 shares of Context Therapeutics Inc (CNTX) as of August 16, 2022, with a value of $21,999.

Latest Holdings of Tarek Sahmoud

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNTX Context Therapeutics Inc 2022-08-16 10,000 2.20 21,999

Holding Weightings of Tarek Sahmoud


Tarek Sahmoud Form 4 Trading Tracker

According to the SEC Form 4 filings, Tarek Sahmoud has made a total of 1 transactions in Context Therapeutics Inc (CNTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Context Therapeutics Inc is the acquisition of 10,000 shares on August 16, 2022, which cost Tarek Sahmoud around $19,500.

Insider Trading History of Tarek Sahmoud

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tarek Sahmoud Trading Performance

GuruFocus tracks the stock performance after each of Tarek Sahmoud's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tarek Sahmoud is -37.5%. GuruFocus also compares Tarek Sahmoud's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tarek Sahmoud within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tarek Sahmoud's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tarek Sahmoud

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -24.48 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -14.45 LIMIT LIMIT LIMIT LIMIT LIMIT

Tarek Sahmoud Ownership Network

Ownership Network List of Tarek Sahmoud

No Data

Ownership Network Relation of Tarek Sahmoud

Insider Network Chart

Tarek Sahmoud Owned Company Details

What does Context Therapeutics Inc do?

Who are the key executives at Context Therapeutics Inc?

Tarek Sahmoud is the Chief Medical Officer of Context Therapeutics Inc. Other key executives at Context Therapeutics Inc include director & Chief Executive Officer Martin A. Lehr , Chief Financial Officer Jennifer Lynn Minai-azary , and Chief Legal Officer & Corp. Sec Alex C. Levit .

Context Therapeutics Inc (CNTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Context Therapeutics Inc (CNTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Context Therapeutics Inc (CNTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Context Therapeutics Inc (CNTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Context Therapeutics Inc Insider Transactions

No Available Data

Tarek Sahmoud Mailing Address

Above is the net worth, insider trading, and ownership report for Tarek Sahmoud. You might contact Tarek Sahmoud via mailing address: 3675 Market Street, Suite 200, Philadelphia Pa 19104.